Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Yue, Yaofei ^a   Yang, Hongying ^b   Wu, Kun ^b   Yang, Lijuan ^a   Chen, Junying ^a   Huang, Xinwei ^a   Pan, Yue ^a   Ruan, Youqing ^b   Zhao, Yujiao ^a   Shi, Xinan ^c   Sun, Qiangming ^a   Li, Qihan ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c Southwest Guizhou Vocational and Technical College for Nationalities   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN L1;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BETA TURN; CHINA; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 58; L1 GENE; L2 GENE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PROTEIN SECONDARY STRUCTURE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS GENE; VIRUS INFECTIVITY;

AMINO ACID SUBSTITUTION; CAPSID PROTEINS; CHINA; FEMALE; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84872873922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055204     Document Type: Article

References (49)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, H zH, (2004) Classification of papillomaviruses. Virology 324: 17-27.
2. H zH, (1996) Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288: F55-F78.
3. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, EL F, (2011) Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 53: S12-21.
4. Garbuglia AR, Carletti F, Minosse C, Piselli P, Zaniratti MS, et al. (2007) Genetic variability in E6 and E7 genes of human papillomavirus-16,-18,-31 and-33 from HIV-1-positive women in Italy. New Microbiol 30: 377-382.
5. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
6. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, et al. (2008) Arrangement of L2 within the Papillomavirus Capsid. J Virol 82: 5190-5197.
7. Trus BL, Roden RB, Greenstone HL, Vrhel M, Schiller JT, et al. (1997) Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution. Nat Struct Biol 4: 413-420.
8. Bishop B, Dasgupta J, Klein M, Garcea RL, Christensen ND, et al. (2007) Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies. J Biol Chem 282: 31803-31811.
9. Moscicki AB, JS S (2008) Issues in human papillomavirus vaccination in adolescents. J Adolesc Health 43: S 1-S4.
10. Bossis I, Roden RB, Gambhira R, Yang R, Tagaya M, et al. (2005) Interaction of tSNARE Syntaxin 18 with the Papillomavirus Minor Capsid Protein Mediates Infection. J Virol 79: 6723-6731.
11. Kondo K, Ishii Y, Ochi H, Matsumoto T, Yoshikawa H, et al. (2007) Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology 358: 266-272.
12. Pastrana DV, Gambhira R, Buck CB, Pang YY, Thompson CD, et al. (2005) Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Virology 337: 365-372.
13. Malagón T, Drolet M, Boily MC, Franco EL, Jit M, et al. (2012) Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12: 781-789.
14. Pereira R, Hitzeroth II, EP R, (2009) Insights into the role and function of L2, the minor capsid protein of papillomaviruses. Arch Virol 154: 187-197.
15. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, et al. (1997) PCR Detection of Human Papillomavirus: Comparison between MY09/MY11 and GP51/GP61 Primer Systems. J Clin Microbilo 35: 1304-1310.
16. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, PJ S, (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papilloma-virus detection by PCR. J Gen Virol 76: 1057-1062.
17. Frati E, Bianchi S, Colzani D, Zappa A, Orlando G, et al. (2011) Genetic variability in the major capsid L1 protein of human papillomavirus type 16 (HPV-16) and 18 (HPV-18). Infect Genet Evol 11: 2119-2124.
18. J F, (1982) Numerical methods for inferring evolutionary trees. Q Rev Biol 57: 379-404.
19. J F, (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39: 783-791.
20. J F, (1989) PHYLIP - phylogeny inference package (version 3 2). Cladistics 5: 164-166.
21. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, et al. (1995) Human Papillomavirus Type 16 Variant Lineages in United States Populations Characterized by Nucleotide Sequence Analysis of the E6, L2, and L1 Coding Segments. J Virol 69: 7743-7753.
22. Nei M, T G, (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3: 418-426.
23. Hamza AA, Robene-Soustrade I, Jouen E LP, Chiroleu F, Fisher-Le Saux M, et al. (2012) MultiLocus Sequence Analysis- and Amplified Fragment Length Polymorphism-based characterization of xanthomonads associated with bacterial spot of tomato and pepper and their relatedness to Xanthomonas species. Syst Appl Microbiol 35: 183-190.
24. Karanam B, Jagu S, Huh WK, RB R, (2009) Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection. Immunol Cell Biol 87: 287-299.
25. Z Y, (2007) PAML 4: Phylogenetic Analysis by Maximum Likelihood. Mol Biol Evol 24: 1586-1591.
26. Yue YF, Yang LJ, Chen JY, Pan Y, Zhao YJ, et al. (2012) Genetic Subtypes and Distribution of HPV from 3000 volunteer outpatients in Yunnan Province. Chinese Journal of Obstetrics & Gynecology and Pediatrics (Electronic Edition) 8: 467-470.
27. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, et al. (1995) Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective. J Natl Cancer Inst 87: 796-802.
28. Clifford GM, Smith JS, Plummer M, Munoz N, S F, (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta analysis. Br J Cancer 88: 63-73.
29. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11: 1048-1056.
30. Sun ZR, Ji YH, Zhou WQ, Zhang SL, Jiang WG, et al. (2010) Characteristics of HPV prevalence among women in Liaoning province, China. Int J Gynaecol Obstet 109: 105-109.
31. Camara GN, Cerqueira DM, Oliveira AP, Silva EO, Carvalho LG, et al. (2003) Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz 98: 879-883.
32. Bae JH, Lee SJ, Kim CJ, Hur SY, Park YG, et al. (2008) Human papillomavirus (HPV) type distribution in Korean women: A meta-analysis. J Microbiol Biotechnol 18: 788-794.
33. Sasagawa T, Basha W, Yamazaki H, M I, (2001) High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10: 45-52.
34. Chan PK, Li WH, Chan MY, Ma WL, Cheung JL, et al. (1999) High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and pre-cancerous lesions. J Med Virol 59: 232-238.
35. Wu Y, Chen Y, Li L, Yu G, Zhang Y, et al. (2006) Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35: 264-269.
36. Liu J, Rose B, Huang X, Liao G, Carter J, et al. (2004) Comparative analysis of characteristics of women with cervical cancer in highversus low-incidence regions. Gynecol Oncol 94: 803-810.
37. Lai CH, Chao A, Chang CJ, Chao FY, Huang HJ, et al. (2008) Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan. Int J Cancer 123: 1685-1692.
38. Xin CY, Matsumoto K, Yoshikawa H, Yasugi T, Onda T, et al. (2001) Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 170: 19-24.
39. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, et al. (2002) Association of Human Papillomavirus Type 58 Variant With the Risk of Cervical Cancer. J Natl Cancer Inst 94: 1249-1253.
40. Lin QQ, Yu SZ, Qu W, Cruz Y, RD B, (1998) Human papillomavirus types 52 and 58. Int J Cancer 75: 484-485.
41. Lai HC, Sun CA, Yu MH, Chen HJ, Liu HS, et al. (1999) Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types Int J Cancer. 84: 553-557.
42. Huang S, Afonina I, Miller BA, AM B, (1997) Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70: 408-411.
43. Ding T, Wang X, Ye F, Cheng X, Ma D, et al. (2010) Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women. Gynecol Oncol 119: 436-443.
44. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, et al. (2001) Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer. J Natl Cancer Inst 93: 315-318.
45. Pista A, Oliveira A, Barateiro A, Costa H, Verdasca N, et al. (2007) Molecular variants of human papillomavirus type 16 and 18 and risk for cervical Neoplasia in Portugal. J Med Virol 79: 1889-1897.
46. Chaturvedi AK, Dumestre J, Gaffga AM, Mire KM, Clark RA, et al. (2005) Prevalence of human papillomavirus genotypes in women from three clinical settings. J Med Virol 75: 105-113.
47. Stewart AC, Eriksson AM, Manos MM, Muñoz N, Bosch FX, et al. (1996) Intratype Variation in 12 Human Papillomavirus Types:a Worldwide Perspective. J Virol 70: 3127-3136.
48. Fukui A, Matsueda S, Kawano K, Tsuda N, Komatsu N, et al. (2012) Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides. Virol J 9: 199-204.
49. Cerqueira DM, de S Moraes D, Camara GN, Amaral FA, Oyama CN, et al. (2006) High HPV genetic diversity in women infected with HIV-1 in Brazil. Arch Virol 152: 75-83.